Abstract
Background and aims: The prevalence of the metabolic syndrome increases with age, although only few data are available about its prevalence in the general elderly population. This study describes the prevalence of the metabolic syndrome in an elderly population, and its association with cardiovascular diseases. Methods: The Progetto Veneto Anziani (Pro.V.A.) is an observational study of 3099 subjects aged 65 and older, randomly selected from the general population of Northern Italy. Cardiovascular diseases and metabolic syndrome according to Adult Treatment Panel III were evaluated in 2910 subjects. Results: The metabolic syndrome was present in 25.6% of men and 48.1% of women. Its prevalence was mainly due to high blood pressure (93%) in both sexes, and to abdominal obesity in 73% of women. The prevalence of cardiovascular diseases was significantly higher among subjects with metabolic syndrome. Together with age and former smoking habits, the metabolic syndrome was significantly associated with cardiovascular diseases. High blood pressure and low HDL were independently associated with cardiovascular diseases in men, and with high fasting plasma glucose and waist circumference in women. Conclusions: The metabolic syndrome is frequent, and significantly but not independently associated with prevalent cardiovascular diseases in the elderly. In old people, rather than the metabolic syndrome per se, some of its components are independently associated with cardiovascular diseases.
Similar content being viewed by others
References
Avogaro P, Crepaldi G, Enzi G, Tiengo A. Association of hyperlipemia, diabetes mellitus and mild obesity. Ada Diabetol Lat 1967; 4: 572–90.
Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
Ferrannini E, Haffner SM, Mitchell BD, Stern MP. Hyperinsulinaemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416–22.
Report of a WHO Consultation. In: Alwan A, King H, eds. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva: World Health Organization, Department of Noncommu-nicable Disease Surveillance, 1999: 1–59.
Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486–97.
McNeill AM, Rosamond WD, Girman CJ, et al. The metabolic syndrome and 11-year risk of incident cardiovascular disease in the Atherosclerosis Risk in Communities study. Diabetes Care 2005; 28: 385–90.
Lakka HM, Laaksonen DE, Lakka TA, et al. The metabolic syndrome and total and cardiovascular disease mortality in middleaged men. JAMA 2002; 288: 2709–16.
Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 2002; 287: 356 9.
Scuteri A, Najjar SS, Morrell CH, Lakatta EG. The metabolic syndrome in older individuals: prevalence and prediction of cardiovascular events: the Cardiovascular Health Study. Diabetes Care 2005; 28: 882–7.
Bonora E, Kiechl S, Willeit J, et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes 2003; 27: 1283–9.
Miccoli R, Bianchi C, Odoguardi L, et al. Prevalence of the metabolic syndrome among Italian adults according to the ATPIII definition. Nutr Metab Cardiovasc Dis 2005; 15: 250–4.
Maggi S, Noale M, Gallina P, et al. Metabolic syndrome, diabetes and cardiovascular disease in an elderly Caucasian cohort. The Italian Longitudinal Study of Aging. J Gerontol Med Sci 2006; 61: 505–10.
Corti MC, Guralnik JM, Sartori L, et al. The effect of cardiovascular and osteoarticular diseases on disability in older Italian men and women: rationale, design, and sample characteristics of the Progetto Veneto Anziani (PRO.V.A.) Study. J Am Geriatr Soc 2002; 50: 153540.
Ravaglia G, Forti P, Maioli F, et al. Metabolic Syndrome. Prevalence and prediction of mortality in elderly individuals. Diabetes Care 2006; 29: 2471–6.
McNeill AM, Rosamond WD, Girman CJ, et al. Prevalence of coronary heart disease and carotid arterial thickening in patients with the metabolic syndrome. (The ARIC Study). Am J Cardiol 2004; 94: 1249–54.
Imperatore G, Riccardi G, Iovine C, Rivellese A, Vaccaro O. Plasma fibrinogen: a new factor of the metabolic syndrome. A populationbased study. Diabetes Care 1998; 21: 649–54.
Festa A, D’Agostino R Jr, Howard G, Mykkanen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000; 102: 42–7.
Jeong SK, Nam HS, Rhee JA, Shin JH, Kim JM, Cho KH. Metabolic syndrome and ALT: a community study in adult Koreans. Int J Obes 2004; 28: 1033–8.
Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346: 1221–31.
Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death. A population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164: 1422–6.
Hetmann BL, Frederiksen P, Lissner L. Hip circumference and cardiovascular morbidity and mortality in men and women. Obes Res 2004; 12: 482–7.
Dey DK, Lissner L. Obesity in 70-year-old subjects as a risk factor for 15-year coronary heart disease incidence. Obes Res 2003; 11: 817–27.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Manzato, E., Romanato, G., Zambon, S. et al. Metabolic syndrome and cardiovascular disease in the elderly: the Progetto Veneto Anziani (Pro.V.A.) Study. Aging Clin Exp Res 20, 47–52 (2008). https://doi.org/10.1007/BF03324747
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03324747